| 0 (0%) | 10-15 12:14 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 110.82  |
1-year : | 116.08 |
| Resists | First : | 94.88 |
Second : | 99.38 |
| Pivot price | 90.8 |
|||
| Supports | First : | 87.59 | Second : | 72.88 |
| MAs | MA(5) : | 89.56 |
MA(20) : | 92.13 |
| MA(100) : | 77.74 |
MA(250) : | 67.5 |
|
| MACD | MACD : | -0.7 |
Signal : | 0 |
| %K %D | K(14,3) : | 16.2 |
D(3) : | 14.7 |
| RSI | RSI(14): 44.8 |
|||
| 52-week | High : | 99.5 | Low : | 52.5 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ANIP ] has closed above bottom band by 34.5%. Bollinger Bands are 48.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 89.51 - 90.11 | 90.11 - 90.64 |
| Low: | 86.12 - 86.88 | 86.88 - 87.57 |
| Close: | 87.57 - 88.76 | 88.76 - 89.84 |
Wed, 15 Oct 2025
ANI Pharmaceuticals (ANIP): Exploring Valuation After Year-to-Date 60% Share Price Surge - simplywall.st
Wed, 15 Oct 2025
Ranking ANIP among high performing stocks via tools - Insider Selling & Free Verified High Yield Trade Plans - newser.com
Tue, 14 Oct 2025
Ranking ANIP among high performing stocks via tools - July 2025 Decliners & Weekly Top Gainers Alerts - newser.com
Tue, 14 Oct 2025
Assessing Valuation: ANI Pharmaceuticals (ANIP) Up 60% Year-to-Date—Is the Market Overlooking Growth? - Yahoo Finance
Fri, 10 Oct 2025
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - sharewise.com
Fri, 10 Oct 2025
3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP) - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 22 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 10.1 (%) |
| Held by Institutions | 95.3 (%) |
| Shares Short | 2,330 (K) |
| Shares Short P.Month | 2,040 (K) |
| EPS | -0.69 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 21.7 |
| Profit Margin | -1.4 % |
| Operating Margin | 7.1 % |
| Return on Assets (ttm) | 1 % |
| Return on Equity (ttm) | -2.2 % |
| Qtrly Rev. Growth | 53 % |
| Gross Profit (p.s.) | 20.47 |
| Sales Per Share | 33.53 |
| EBITDA (p.s.) | 4.68 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 139 (M) |
| Levered Free Cash Flow | 89 (M) |
| PE Ratio | -130.3 |
| PEG Ratio | 0 |
| Price to Book value | 4.14 |
| Price to Sales | 2.68 |
| Price to Cash Flow | 14.4 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|